Delivery Order SPE2DB20D3103-SPE2DB24FM6A8

Award Date 2/8/24
Potential Completion Date 2/9/24
Potential Value $3.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VALTOCO 10 MG NASAL SPRAYS to the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of the prime contractor Amerisourcebergen Drug Corp Corporate Office Division. The contract, valued at $1,253.65, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a...
This federal contract award is for the purchase of VALTOCO 10 MG NASAL SPRAYS by the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,078.62 and is a firm fixed-price delivery order, with an ultimate completion date of January 7, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a...
This federal contract award is a delivery order valued at $6,812.46 issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VALTOCO 15 MG NASAL SPRAYS to support the Medical Supply Chain program of the Defense Logistics Agency (DLA). The contract has a completion date of February 21, 2025 and is a firm fixed price arrangement. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of VALTOCO 10 MG NASAL SPRAYS to the Defense Logistics Agency (DLA). The $1,218.12 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 24, 2023, with a completion date of November 27, 2023. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of VALTOCO 10 MG NASAL SPRAYS to the Defense Logistics Agency (DLA). The contract, awarded to prime contractor Amerisourcebergen Drug Corp, has a ceiling value of $2,274.92 and runs through January 15, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,560.48 firm fixed-price delivery order is for the purchase of VALTOCO 10 MG nasal sprays. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, which runs through November 2026, enables the efficient procurement of a...
This federal contract award, valued at $3,839.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VALTOCO 15 MG NASAL SPRAYS, a pharmaceutical product. The contract has an ultimate completion date of April 2, 2025 and is a firm fixed-price agreement. This contract award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $1,303.58, was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the delivery of VALTOCO 15 MG NASAL SPRAYS. The contract has an ultimate completion date of July 9, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through...
The federal contract award is for the delivery of VALTOCO 15 MG NASAL SPRAYS to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,079.48 firm fixed-price contract has a completion date of December 11, 2024 and was awarded on December 10, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization that is registered...
This federal contract award is for the delivery of VALTOCO 10 MG NASAL SPRAYS to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 10, 2024, with a ceiling value of $1,184.97 and an ultimate completion date of December 11, 2024. The contract is a Delivery Order under a larger Indefinite Delivery...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM6A8
    Delivery Order

This federal contract award is for the delivery of VALTOCO 15 MG NASAL SPRAYS to the Defense Logistics Agency (DLA). The contract, valued at $3,389.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999 IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive experience in pharmaceutical distribution and its established relationships with the DLA and other federal agencies have positioned the company as a key supplier of essential medical commodities to the U.S. government's defense and healthcare programs.

Generated 5/14/25, 9:50 AM